Skip Navigation LinksHome > July 2009 - Volume 338 - Issue 1 > Folic Acid Supplementation and Cardiovascular Disease: The S...
American Journal of the Medical Sciences:
doi: 10.1097/MAJ.0b013e3181aaefd6
Symposium Articles

Folic Acid Supplementation and Cardiovascular Disease: The State of the Art.

Bazzano, Lydia A. MD, PhD

Collapse Box


High levels of homocysteine, a non-protein-forming, sulfur-containing amino acid, have been associated with elevated cardiovascular risk in observational studies. Support for the homocysteine hypothesis comes from 2 primary lines of epidemiologic evidence, observational studies, such as case control and cohort studies, and studies of genetic variation. On the basis of unequivocally supportive epidemiologic data, a series of large randomized controlled trials of homocysteine lowering through folic acid supplementation were launched. The recently reported results of the 3 large, randomized clinical trials (SEARCH, WENBIT, WAFACS) in combination with those previously reported (CHAOS-2, VISP, NORVIT, HOPE-2) effectively rule out the possibility of large effect on risk of coronary heart disease, stroke, and all-cause mortality. Although the potential for prevention of atherosclerotic cardiovascular disease in adults through folic acid supplementation has not yet been substantiated, folic acid supplementation prenatally may reduce congenital heart defects in offspring.

© Copyright 2009 Southern Society for Clinical Investigation


Article Tools


Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.